Free Trial

Yatsen (YSG) Competitors

Yatsen logo
$2.62 +0.06 (+2.34%)
As of 11:28 AM Eastern
This is a fair market value price provided by Massive. Learn more.

YSG vs. BWMX, HNST, PRE, USNA, and NUS

Should you buy Yatsen stock or one of its competitors? Yatsen's main competitors and comparable companies include Betterware de Mexico SAPI de C (BWMX), Honest (HNST), Prenetics Global (PRE), USANA Health Sciences (USNA), and Nu Skin Enterprises (NUS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does Yatsen compare to Betterware de Mexico SAPI de C?

Betterware de Mexico SAPI de C (NYSE:BWMX) and Yatsen (NYSE:YSG) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

12.7% of Betterware de Mexico SAPI de C shares are held by institutional investors. 29.0% of Yatsen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Betterware de Mexico SAPI de C had 1 more articles in the media than Yatsen. MarketBeat recorded 1 mentions for Betterware de Mexico SAPI de C and 0 mentions for Yatsen. Betterware de Mexico SAPI de C's average media sentiment score of 1.02 beat Yatsen's score of 0.00 indicating that Betterware de Mexico SAPI de C is being referred to more favorably in the media.

Company Overall Sentiment
Betterware de Mexico SAPI de C Positive
Yatsen Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Betterware de Mexico SAPI de C
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.67
Yatsen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Betterware de Mexico SAPI de C has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market. Comparatively, Yatsen has a beta of -1.71, indicating that its stock price is 271% less volatile than the broader market.

Betterware de Mexico SAPI de C has higher revenue and earnings than Yatsen. Yatsen is trading at a lower price-to-earnings ratio than Betterware de Mexico SAPI de C, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Betterware de Mexico SAPI de C$744M0.87$55.37M$1.838.93
Yatsen$614.62M0.39-$11.56M-$0.32N/A

Betterware de Mexico SAPI de C has a net margin of 8.35% compared to Yatsen's net margin of -4.63%. Betterware de Mexico SAPI de C's return on equity of 77.89% beat Yatsen's return on equity.

Company Net Margins Return on Equity Return on Assets
Betterware de Mexico SAPI de C8.35% 77.89% 11.28%
Yatsen -4.63%-7.26%-5.42%

Summary

Betterware de Mexico SAPI de C beats Yatsen on 14 of the 15 factors compared between the two stocks.

How does Yatsen compare to Honest?

Honest (NASDAQ:HNST) and Yatsen (NYSE:YSG) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability and risk.

In the previous week, Honest had 1 more articles in the media than Yatsen. MarketBeat recorded 1 mentions for Honest and 0 mentions for Yatsen. Honest's average media sentiment score of 1.65 beat Yatsen's score of 0.00 indicating that Honest is being referred to more favorably in the media.

Company Overall Sentiment
Honest Very Positive
Yatsen Neutral

Yatsen has higher revenue and earnings than Honest. Honest is trading at a lower price-to-earnings ratio than Yatsen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Honest$371.32M1.49-$15.69M-$0.11N/A
Yatsen$614.62M0.39-$11.56M-$0.32N/A

Honest has a beta of 2.32, meaning that its stock price is 132% more volatile than the broader market. Comparatively, Yatsen has a beta of -1.71, meaning that its stock price is 271% less volatile than the broader market.

45.5% of Honest shares are held by institutional investors. 9.4% of Honest shares are held by insiders. Comparatively, 29.0% of Yatsen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Honest has a net margin of -3.56% compared to Yatsen's net margin of -4.63%. Honest's return on equity of 4.31% beat Yatsen's return on equity.

Company Net Margins Return on Equity Return on Assets
Honest-3.56% 4.31% 3.33%
Yatsen -4.63%-7.26%-5.42%

Honest presently has a consensus price target of $4.84, indicating a potential downside of 3.78%. Given Honest's stronger consensus rating and higher possible upside, analysts clearly believe Honest is more favorable than Yatsen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Honest
2 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.22
Yatsen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Honest beats Yatsen on 13 of the 17 factors compared between the two stocks.

How does Yatsen compare to Prenetics Global?

Yatsen (NYSE:YSG) and Prenetics Global (NASDAQ:PRE) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability.

Yatsen has a net margin of -4.63% compared to Prenetics Global's net margin of -47.43%. Yatsen's return on equity of -7.26% beat Prenetics Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Yatsen-4.63% -7.26% -5.42%
Prenetics Global -47.43%-21.41%-15.56%

Yatsen has higher revenue and earnings than Prenetics Global. Yatsen is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Yatsen$614.62M0.39-$11.56M-$0.32N/A
Prenetics Global$154.59M2.23-$37.71M-$4.16N/A

Prenetics Global has a consensus target price of $35.67, indicating a potential upside of 74.84%. Given Prenetics Global's stronger consensus rating and higher probable upside, analysts clearly believe Prenetics Global is more favorable than Yatsen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Yatsen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Prenetics Global
1 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.71

In the previous week, Prenetics Global had 1 more articles in the media than Yatsen. MarketBeat recorded 1 mentions for Prenetics Global and 0 mentions for Yatsen. Prenetics Global's average media sentiment score of 1.17 beat Yatsen's score of 0.00 indicating that Prenetics Global is being referred to more favorably in the news media.

Company Overall Sentiment
Yatsen Neutral
Prenetics Global Positive

Yatsen has a beta of -1.71, suggesting that its share price is 271% less volatile than the broader market. Comparatively, Prenetics Global has a beta of 0.35, suggesting that its share price is 65% less volatile than the broader market.

25.0% of Prenetics Global shares are held by institutional investors. 29.0% of Yatsen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Prenetics Global beats Yatsen on 9 of the 16 factors compared between the two stocks.

How does Yatsen compare to USANA Health Sciences?

Yatsen (NYSE:YSG) and USANA Health Sciences (NYSE:USNA) are both small-cap consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, media sentiment, dividends and valuation.

54.3% of USANA Health Sciences shares are held by institutional investors. 29.0% of Yatsen shares are held by company insiders. Comparatively, 0.8% of USANA Health Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Yatsen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
USANA Health Sciences
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

USANA Health Sciences has a net margin of -2.43% compared to Yatsen's net margin of -4.63%. USANA Health Sciences' return on equity of 3.41% beat Yatsen's return on equity.

Company Net Margins Return on Equity Return on Assets
Yatsen-4.63% -7.26% -5.42%
USANA Health Sciences -2.43%3.41%2.50%

Yatsen has a beta of -1.71, meaning that its share price is 271% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market.

In the previous week, USANA Health Sciences had 6 more articles in the media than Yatsen. MarketBeat recorded 6 mentions for USANA Health Sciences and 0 mentions for Yatsen. USANA Health Sciences' average media sentiment score of 0.03 beat Yatsen's score of 0.00 indicating that USANA Health Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Yatsen Neutral
USANA Health Sciences Neutral

USANA Health Sciences has higher revenue and earnings than Yatsen. USANA Health Sciences is trading at a lower price-to-earnings ratio than Yatsen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Yatsen$614.62M0.39-$11.56M-$0.32N/A
USANA Health Sciences$925.26M0.30$10.76M-$1.21N/A

Summary

USANA Health Sciences beats Yatsen on 10 of the 14 factors compared between the two stocks.

How does Yatsen compare to Nu Skin Enterprises?

Nu Skin Enterprises (NYSE:NUS) and Yatsen (NYSE:YSG) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.

In the previous week, Nu Skin Enterprises' average media sentiment score of 0.38 beat Yatsen's score of 0.00 indicating that Nu Skin Enterprises is being referred to more favorably in the media.

Company Overall Sentiment
Nu Skin Enterprises Neutral
Yatsen Neutral

82.8% of Nu Skin Enterprises shares are held by institutional investors. 2.8% of Nu Skin Enterprises shares are held by insiders. Comparatively, 29.0% of Yatsen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Nu Skin Enterprises has a beta of 0.91, suggesting that its share price is 9% less volatile than the broader market. Comparatively, Yatsen has a beta of -1.71, suggesting that its share price is 271% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nu Skin Enterprises
2 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Yatsen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Nu Skin Enterprises has higher revenue and earnings than Yatsen. Yatsen is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nu Skin Enterprises$1.49B0.16$160.20M-$4.47N/A
Yatsen$614.62M0.39-$11.56M-$0.32N/A

Yatsen has a net margin of -4.63% compared to Nu Skin Enterprises' net margin of -15.73%. Nu Skin Enterprises' return on equity of 6.58% beat Yatsen's return on equity.

Company Net Margins Return on Equity Return on Assets
Nu Skin Enterprises-15.73% 6.58% 3.63%
Yatsen -4.63%-7.26%-5.42%

Summary

Nu Skin Enterprises beats Yatsen on 8 of the 12 factors compared between the two stocks.

Get Yatsen News Delivered to You Automatically

Sign up to receive the latest news and ratings for YSG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding YSG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

YSG vs. The Competition

MetricYatsenPersonal Care Products IndustryConsumer Staples SectorNYSE Exchange
Market Cap$244.82M$22.76B$15.54B$22.76B
Dividend YieldN/A5.53%3.34%3.72%
P/E Ratio-8.1621.1013.7627.77
Price / Sales0.4012.59264,296.7314.48
Price / Cash322.4626.3657.0036.95
Price / Book0.572.834.284.66
Net Income-$11.56M$1.13B$839.81M$1.07B
7 Day Performance-6.36%-0.82%-0.39%0.10%
1 Month Performance-0.38%-7.49%-4.74%-6.10%
1 Year Performance-66.11%-22.67%7.92%5.40%

Yatsen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
YSG
Yatsen
0.3853 of 5 stars
$2.62
+2.3%
N/A-68.8%$244.82M$614.62MN/A1,623
BWMX
Betterware de Mexico SAPI de C
4.677 of 5 stars
$16.35
+0.2%
N/A+27.4%$645.54M$744M8.932,441
HNST
Honest
2.4879 of 5 stars
$5.03
-2.3%
$4.84
-3.8%
+26.7%$553.70M$342.01MN/A174
PRE
Prenetics Global
4.5637 of 5 stars
$20.40
-2.7%
$35.67
+74.8%
+36.2%$344.15M$92.39MN/A98
USNA
USANA Health Sciences
1.5378 of 5 stars
$14.91
+0.4%
N/A-44.0%$275.57M$913.36MN/A1,570

Related Companies and Tools


This page (NYSE:YSG) was last updated on 10/7/2026 by MarketBeat.com Staff.
From Our Partners